- Home
- Publications
- Publication Search
- Publication Details
Title
SUMO-modifying Huntington’s disease
Authors
Keywords
Huntingtin, Huntington’s disease, Neurodegeneration, Post-translational modification, SUMO, SUMOylation
Journal
IBRO Neuroscience Reports
Volume 12, Issue -, Pages 203-209
Publisher
Elsevier BV
Online
2022-03-10
DOI
10.1016/j.ibneur.2022.03.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington’s disease
- (2021) Eva L. Morozko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Altered Gut Microbiota Related to Inflammatory Responses in Patients With Huntington’s Disease
- (2021) Gang Du et al. Frontiers in Immunology
- Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons’ Degeneration: Link to Parkinson’s Disease
- (2021) Marcello Serra et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Huntingtin and the Synapse
- (2021) Jessica C. Barron et al. Frontiers in Cellular Neuroscience
- Molecular mechanisms in SUMO conjugation
- (2020) Nathalia Varejão et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts
- (2020) Arda B. Celen et al. FEBS Journal
- Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review
- (2020) Larissa-Nele Schaffert et al. Brain Sciences
- Loss of Hap1 selectively promotes striatal degeneration in Huntington disease mice
- (2020) Qiong Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Site‐Specific Phosphorylation of Huntingtin Exon 1 Recombinant Proteins Enabled by the Discovery of Novel Kinases
- (2020) Anass Chiki et al. CHEMBIOCHEM
- Evaluation of post-translational modifications in histone proteins: A review on histone modification defects in developmental and neurological disorders
- (2020) Shahin Ramazi et al. JOURNAL OF BIOSCIENCES
- Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
- (2020) Sarah J. Tabrizi et al. Nature Reviews Neurology
- SUMO: From Bench to Bedside
- (2020) Hui-Ming Chang et al. PHYSIOLOGICAL REVIEWS
- A Chain of Events: Regulating Target Proteins by SUMO Polymers
- (2020) Nicolette S. Jansen et al. TRENDS IN BIOCHEMICAL SCIENCES
- Deciphering protein post-translational modifications using chemical biology tools
- (2020) Anne C. Conibear Nature Reviews Chemistry
- Rhes travels from cell to cell and transports Huntington disease protein via TNT-like protrusion
- (2019) Manish Sharma et al. JOURNAL OF CELL BIOLOGY
- SUMOylation in Neurodegenerative Diseases
- (2019) Andrea Princz et al. GERONTOLOGY
- SUMOylation Prevents Huntingtin Fibrillization and Localization onto Lipid Membranes
- (2019) Faezeh Sedighi et al. ACS Chemical Neuroscience
- Regulation of HSF1 protein stabilization: An updated review
- (2018) Chao Huang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Thyroid Hormone-target Gene Rhes a Novel Crossroad for Neurological and Psychiatric Disorders: New Insights from Animal Models
- (2018) Francesco Napolitano et al. NEUROSCIENCE
- An overview of the possible therapeutic role of SUMOylation in the treatment of Alzheimer’s disease
- (2018) S. Marcelli et al. PHARMACOLOGICAL RESEARCH
- Huntington disease: A quarter century of progress since the gene discovery
- (2018) Claudia M. Testa et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A role for autophagy in Huntington's disease
- (2018) Katherine R. Croce et al. NEUROBIOLOGY OF DISEASE
- SUMO-Targeted Ubiquitin Ligases (STUbLs) Reduce the Toxicity and Abnormal Transcriptional Activity Associated With a Mutant, Aggregation-Prone Fragment of Huntingtin
- (2018) Kentaro Ohkuni et al. Frontiers in Genetics
- Huntington's disease: a clinical review
- (2017) P. McColgan et al. EUROPEAN JOURNAL OF NEUROLOGY
- Increased SUMO-2/3-ylation mediated by SENP3 degradation is protective against cadmium-induced caspase 3–dependent cytotoxicity
- (2017) Jia Luo et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Transcriptional profiles for distinct aggregation states of mutant Huntingtin exon 1 protein unmask new Huntington's disease pathways
- (2017) Nagaraj S. Moily et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- SUMO-regulated mitochondrial function in Parkinson's disease
- (2016) Ana Cristina Guerra de Souza et al. JOURNAL OF NEUROCHEMISTRY
- PIAS1 Regulates Mutant Huntingtin Accumulation and Huntington’s Disease-Associated Phenotypes In Vivo
- (2016) Joseph Ochaba et al. NEURON
- The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration
- (2015) Jennifer M. Deger et al. AGING CELL
- Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease
- (2015) Supriya Swarnkar et al. NEUROBIOLOGY OF DISEASE
- Battling Alzheimer’s Disease: Targeting SUMOylation-Mediated Pathways
- (2015) Wagner Carbolin Martins et al. NEUROCHEMICAL RESEARCH
- Cellular maintenance of nuclear protein homeostasis
- (2013) Pamela S. Gallagher et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The role of Rhes, Ras homolog enriched in striatum, in neurodegenerative processes
- (2013) Laura M. Harrison et al. EXPERIMENTAL CELL RESEARCH
- SUMO-2 and PIAS1 Modulate Insoluble Mutant Huntingtin Protein Accumulation
- (2013) Jacqueline Gire O’Rourke et al. Cell Reports
- Suppression of protein aggregation by chaperone modification of high molecular weight complexes
- (2012) John Labbadia et al. BRAIN
- SUMO-1 is Associated with a Subset of Lysosomes in Glial Protein Aggregate Diseases
- (2012) Mathew B. Wong et al. NEUROTOXICITY RESEARCH
- Biological markers of cognition in prodromal Huntington’s disease: A review
- (2011) Kathryn V. Papp et al. BRAIN AND COGNITION
- The regulation of mitochondrial morphology: Intricate mechanisms and dynamic machinery
- (2011) Catherine S. Palmer et al. CELLULAR SIGNALLING
- Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease
- (2011) U. P. Shirendeb et al. HUMAN MOLECULAR GENETICS
- Small Changes, Big Impact
- (2011) Dagmar E. Ehrnhoefer et al. NEUROSCIENTIST
- Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases
- (2010) P. Hemachandra Reddy et al. BRAIN RESEARCH REVIEWS
- Does Huntingtin play a role in selective macroautophagy?
- (2010) Joan S. Steffan CELL CYCLE
- Rhes, a Physiologic Regulator of Sumoylation, Enhances Cross-sumoylation between the Basic Sumoylation Enzymes E1 and Ubc9
- (2010) Srinivasa Subramaniam et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Huntington’s Disease is a disorder of the corpus striatum: Focus on Rhes (Ras homologue enriched in the striatum)
- (2010) Srinivasa Subramaniam et al. NEUROPHARMACOLOGY
- The role of post-translational modifications of huntingtin in the pathogenesis of Huntington’s disease
- (2010) Yan Wang et al. Neuroscience Bulletin
- IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome
- (2009) Leslie Michels Thompson et al. JOURNAL OF CELL BIOLOGY
- SUMOylation and deSUMOylation at a glance
- (2009) Y. Wang et al. JOURNAL OF CELL SCIENCE
- Beyond the brain: widespread pathology in Huntington's disease
- (2009) Jorien MM van der Burg et al. LANCET NEUROLOGY
- Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeutics
- (2009) Christopher A. Ross et al. PARKINSONISM & RELATED DISORDERS
- Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity
- (2009) S. Subramaniam et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More